Hepatic hydrothorax in the absence of ascites is a rare complication of liver cirrhosis. A 56-year-old woman was referred to our hospital because of a massive pleural effusion on the right side, requiring continuous drainage. 
Introduction
Hepatic hydrothorax, caused by a flow of ascites into the pleural cavity, is a well-known complication of liver cirrhosis. However, pleural effusion in the absence of ascites is a rare condition in patients with liver cirrhosis (1) . In this report, we discuss a patient with marked hepatic hydrothorax but lacking any signs of ascites. Intraperitoneal spraying of indocyanine green (ICG) was helpful to prove that the fluid in the pleural cavity originated from the peritoneal cavity. We also review the previously published reports of 24 cases of hepatic hydrothorax without ascites.
Case Report
A 56-year-old woman with a one-year diagnosis of chronic hepatitis C was admitted to a hospital with a fourday history of dyspnea and a one-week history of dry cough. She had a history of a caesarean section at age 25, but no history of blood transfusions. Decreased breath sounds and dullness on percussion were noted over the lower three-fourths of the right hemithorax. The liver was not palpable below the right costal margin. On physical examination, the patient showed no sign of ascites. Neither palmar erythema nor vascular spider was noted. Laboratory data on admission are shown in Table 1 . Complete blood count values were within normal range, including platelet count, which is usually decreased in patients with liver cirrhosis. Mild elevation of the total bilirubin level (1.7 mg/dl), hypoalbuminemia (3.3 g/dl), and prolongation of prothrombin time (55%) were observed, as well as mild transaminase elevation. An indocyanine green clearance test (ICG R15) showed a high stagnation rate of 37%, suggesting a complication of liver cirrhosis. Although hepatitis B surface antigen was not detected, both hepatitis C virus (HCV) antibody and HCV RNA were detected in the serum, indicating active HCV infection. Urinalysis revealed no proteinuria or other abnormal findings.
Chest X-ray showed massive right-sided pleural effusion (Fig. 1A) . Computed tomography (CT) of the chest revealed no evidence of tumor or lymphadenopathy. Abdominal CT and ultrasonography (US) revealed no ascites or focal hepatic lesion. Furthermore, neither splenomegaly nor collateral flow from the portal vein to the systemic circulation was noted. On endoscopic examination, no esophageal varices were revealed.
Because of the severity of the patient's dyspnea, presumed to be secondary to the massive pleural effusion, a chest tube thoracostomy was performed to allow drainage of the effusion. The characteristics of the pleural effusion suggested its transudatative nature: clear and yellowish fluid, specific gravity of 1.009, total protein level of 0.6 g/dl, and lactic dehydrogenase level of 65 IU/l. No bacteria or fungus was cultured from the effusion. Furthermore, the glucose level (181 mg/dl) was not decreased and adenosine deaminase level (3.8 IU/l) was not increased in the effusion. Cytological examination of the pleural effusion showed no evidence of malignant disease. Because discharge from the pleural drain continued at a level as high as 2,000 ml/day, the patient was transferred to our hospital for further examination and treatment.
On admission, the tube in the chest was left in place to allow continued drainage of the pleural effusion. Repeated examinations of blood chemistry, pleural fluid, and CT of the chest and the abdomen showed no remarkable changes, other than decreased levels of serum albumin (2.1 g/dl) and total protein (5.5 g/dl). These decreased levels were thought to be caused by a loss of proteins through the drained fluid. Echocardiography revealed normal left and right ventricular wall motion and contractility. Neither cardiac, pulmonary, nor renal disease was determined to be the cause of pleural effusion. Because the pleural effusion was thought to be secondary to liver disease, a diagnostic laparoscopy was performed. Laparoscopy ( Fig. 2 ) revealed a nodular and atrophic liver with lymphatic vesicles on its surface. A small volume of ascites was noted within the peritoneal cavity. Liver biopsy was not performed because the patient complained of severe respiratory discomfort during the procedure. Ten milliliters of ICG solution (50 mg/dl) was sprayed intraperitoneally (Fig. 2) to confirm the existence of transdiaphragmatic passage. Overflow of ICG from the chest tube was observed within 3 minutes of spraying (Fig. 3) . These findings suggested an ascitic origin of the pleural fluid, perhaps secondary to liver cirrhosis. Because a hepatic origin of the pleural effusion was suggested, we treated the patient with standard treatments for ascites secondary to liver cirrhosis: bed rest, restriction of salt intake (6 g/day), oral administration of diuretics (furosemide 20 mg/day and spironolactone 50 mg/day), and oral administration of a compound rich in branched-chain amino acids (Livact ® 14.22 g/day). Continuous drainage of the pleural effusion was discontinued upon removal of the right chest tube. Although chest X-ray examinations suggested that the volume of pleural effusion increased temporarily, the volume began to decrease steadily after the dosages of furosemide and spironolactone were increased to 80 mg/day and 100 mg/day, respectively. The patient was discharged from our hospital about 3 weeks after starting the treatment, at which time the pleural effusion had almost disappeared. The patient was followed up in an outpatient clinic of the original hospital and had no recurrence of symptomatic pleural effusion for at least 6 months (Fig. 1B) .
Discussion
Hepatic hydrothorax is defined as the presence of transudative pleural effusion in a patient with cirrhosis of the liver but no primary pulmonary or cardiac disease (2). Leuallen et al reported that 2% of significant pleural effusions are caused by liver cirrhosis (3). It has also been reported that 0.4 to 12.2% of decompensated cirrhosis cases are complicated by pleural effusion (2, 4-7) . Almost all patients with hepatic hydrothorax have been described as having clinically apparent ascites (1). The mechanisms proposed for accumulation of pleural fluid include azygos vein hypertension, hypoproteinemia, and transdiaphragmatic migration of ascitic fluid into the pleural space via lymphatics or diaphragmatic rents (8). Singer et al (9) demonstrated diaphragmatic defects upon autopsy of patients with hepatic hydrothorax but without ascites, and proposed that hepatic hydrothorax without ascites might be caused by a rapid transdiaphragmatic movement of fluid from the peritoneal cavity (higher pressure) to the pleural cavity (lower pressure) prior to the formation of ascites.
Peritoneo-pleural traffic can be proved by demonstrating a diaphragmatic defect at autopsy, at pleuroscopy, and at thoracotomy (9-11). Peritoneo-pleural traffic also can be proved by creation of pneumothorax after intraperitoneal insufflation of air (12) and by an intraperitoneal injection of a radioisotope, which could indicate one-way transdiaphragmatic flow of fluid from the peritoneal cavity to the pleural cavity (1, 8, 10, 11, 13) . However, direct demonstration of a diaphragmatic defect with noninvasive imaging techniques such as US and CT is extremely difficult because the defect itself is usually quite small and not necessarily completely continuous (14) . In the present case, we demonstrated the presence of peritoneo-pleural flow by spraying ICG into the intraperitoneal cavity during laparoscopy. To the best of our knowledge, this is the first report of intraperitoneal spraying of ICG to prove peritoneo-pleural traffic in a case of hepatic hydrothorax without ascites. We think that injection of ICG is as efficient as the use of radioisotopes for providing proof of peritoneo-pleural traffic, and has the advantages of safety and economy over the use of radioisotopes. However, our technique of spraying ICG is only suitable for patients receiving continuous drainage of pleural effusion, because the effusion must be checked immediately after the spraying of ICG.
The treatment for hepatic hydrothorax without ascites includes thoracentesis and chemical (8, 9, 13) or surgical (11) pleurodesis, in addition to the standard treatments for ascites due to liver cirrhosis, such as restriction of salt intake, and administration of diuretics. In the present case, pleural effusion decreased remarkably with a standard treatment for ascites due to liver cirrhosis, which was adopted as soon as the peritoneo-pleural traffic was proved. Thus, it has been shown that accurate determination of the mechanism of pleural effusion is crucial for determining appropriated management strategies in patients with an unusual presentation.
We were able to review reports of 25 cases (including ours) (male : female=12 : 13) with hepatic hydrothorax but without ascites. In these reports, the causes of cirrhosis included heavy drinking in 9 cases, hepatitis B virus (HBV) infection in 3 cases, hepatitis C virus (HCV) infection in 3 cases, hemochromatosis in 2 cases, primary biliary cirrhosis in 1 case, autoimmune hepatitis in 1 case, and unknown in 6 cases. Of the 19 cases with a description of serum albumin level, 12 cases had a level of less than 3.0 g/dl. Of the 14 cases with a known total bilirubin level, 6 cases had a level of less than 2.0 mg/dl. Of the 25 cases reviewed, the administration of diuretics was effective for the treatment of pleural effusion in 12 (6 men and 6 women). Of the 10 cases with both a favorable response to diuretics and with a description of serum albumin level, 6 had a level of less than 3.0 g/dl. Similarly, of the 7 cases with both a favorable response to diuretics and a description of total bilirubin level, 4 cases had a level of less than 2.0 mg/dl. Therefore, the majority of patients with hepatic hydrothorax without ascites had serum albumin levels lower than 3.0 g/dl. In contrast, there was no specific trend in the total serum bilirubin level. Even in patients with serum albumin levels lower than 3.0 g/dl, treatment with diuretics was effective for a considerable portion. Thus, the use of diuretics, which is simple and economical, may be the treatment of choice.
Chemical or surgical pleurodesis was performed on 11 patients. Of these, 3 cases showed marked and continuous decrease of pleural effusion, 1 case showed a temporary decrease, 1 case showed an increase of ascites, and 6 cases showed no change or ended in death. Chemical and surgical pleurodesis must be carefully considered, due to the invasive nature of these procedures and due to their limited efficacy.
In conclusion, even patients with cirrhosis who have considerably high levels of serum albumin (>3.5 g/dl) can develop hepatic hydrothorax without ascites (1) . Failure to accurately diagnose hepatic hydrothorax may result in an erroneous diagnosis such as a cryptogenic pleuritis, especially in patients without ascites. Thus, when pleural effusion is observed in patients with chronic liver disease, it is necessary to consider hepatic hydrothorax as one of the causes, irrespective of the presence or absence of ascites. Intraperitoneal spraying of ICG is valuable for proving peritoneo-pleural traffic in patients with continuous drainage of pleural effusion. (12) Frazer (10) Frazer (10) Faiyaz (13) Rubinstein (11) Rubinstein (11) Llaneza (17) Nolop (18) Davila (19) Albin (8) Jiménez (20) Kirsch (15) Kirsch (15) Kirsch (15) Benet (21) Giacobbe (22) Andrade (23) Mente (1) Mente (1) Hahn (24) Hahn ( 
